Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

253
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
253
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

183
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
183
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

260
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
260
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

163
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
163
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

171
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
171
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

185
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
185

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A CALL FOR STANDARDIZATION OF HYBRID ARCH FROZEN ELEPHANT TRUNK OUTCOMES REPORTING.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Natural History and Impact of Thoracic Endovascular Stent-Grafting on Type B Intramural Hematoma: A World of Caution.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

Sex-specific gene expression signatures of calcific aortic valve stenosis in a large collection of human tissues.

Atherosclerosis·2026
Same author

Reply: Timing modifies the clinical trajectory after failed mitral valve repair.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Association of tricuspid regurgitation with clinical events and quality of life after surgery for severe ischemic mitral regurgitation.

JTCVS structural and endovascular·2026
Same author

Transcatheter Tricuspid Valve Replacement Reduces Heart Failure Hospitalization: Insights From the Canadian Evoque Registry.

The Canadian journal of cardiology·2026

Related Experiment Video

Updated: Dec 18, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.5K

Sizing Strategy and Implant Considerations for the Avalus Valve.

Michael G Moront1, Joseph F Sabik2, Michael J Reardon3

  • 1Department of Cardiothoracic Surgery, ProMedica Toledo Hospital, Toledo, Ohio.

The Annals of Thoracic Surgery
|June 17, 2020
PubMed
Summary

The Avalus valve shows hemodynamic performance comparable to other surgical bioprostheses up to 3 years post-implantation. Surgical technique is key to optimizing these hemodynamic outcomes.

More Related Videos

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.0K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K

Related Experiment Videos

Last Updated: Dec 18, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.5K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.0K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Prosthetic Heart Valves

Background:

  • The Avalus bioprosthesis is a contemporary option for surgical valve replacement.
  • Understanding its long-term hemodynamic performance is crucial for clinical decision-making.
  • Surgical technique is a known modulator of prosthetic valve function.

Purpose of the Study:

  • To evaluate the hemodynamic performance of the Avalus bioprosthesis.
  • To compare its performance to existing surgical bioprostheses.
  • To identify strategies for optimizing hemodynamic outcomes with the Avalus valve.

Main Methods:

  • Retrospective analysis of patient data.
  • Hemodynamic assessment at multiple time points post-implantation.
  • Comparison with contemporary surgical bioprostheses data.

Main Results:

  • Hemodynamic performance of the Avalus valve was comparable to contemporary surgical bioprostheses.
  • Performance was assessed up to 3 years after implantation.
  • Surgical technique influenced hemodynamic outcomes.

Conclusions:

  • The Avalus bioprosthesis demonstrates acceptable hemodynamic performance.
  • Optimal surgical techniques are essential for maximizing hemodynamic benefits.
  • Further research may refine implantation strategies for improved patient outcomes.